CUMBERLAND, R.I.--(BUSINESS WIRE)--Onset Therapeutics, a specialty pharmaceutical company that focuses on the development and commercialization of innovative treatments for skin and skin related disorders, announced the launch of Anestafoam™, a novel topical foam formulation containing lidocaine 4%. Anestafoam™ is the first and only foam formulation of lidocaine on the market. It incorporates the Company’s proprietary Delevo™ Foam Technology and is indicated for the temporary relief of pain associated with minor cuts and scrapes, abrasions, skin irritation, sunburn, burns and insect bites. The Company intends to sell the product primarily to dermatologists and podiatrists through its national field sales force. Anestafoam™ will also be available at retail drug stores and through internet distribution channels.
